Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults 18 years or older
Diagnosis of unresectable stage III and/or metastatic (stage IV) melanoma before 01-Nov-2015
Initiating a new line of therapy during the index period between 01-Jan-2015 and 31-May-2016, irrespective of advanced melanoma diagnosis date
Medical history available for medical chart abstraction from date of diagnosis through most recent or current therapy (defined as end of data collection period)
You may not be if
Physicians unwilling or unable to follow study instructions
Patients who were previously enrolled in a cancer treatment-related clinical trial since the diagnosis of unresectable stage III and/or metastatic (stage IV) melanoma
Clareo Health | Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
